Free Trial
ASX:IHL

Incannex Healthcare (IHL) Stock Price, News & Analysis

Incannex Healthcare logo

About Incannex Healthcare Stock (ASX:IHL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
627,285 shs
Average Volume
N/A
Market Capitalization
A$65.07 million
P/E Ratio
N/A
Dividend Yield
16.80%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Incannex Healthcare and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IHL Stock News Headlines

3 Penny Stocks to Watch Now, 8/28/25
Incannex Reports Positive Phase 2 Trial Results
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
3 Penny Stocks to Watch Now, 8/26/25
Incannex Flat on Looking Ahead to Clinical Trial
See More Headlines

IHL Stock Analysis - Frequently Asked Questions

Incannex Healthcare Limited (ASX:IHL) released its quarterly earnings results on Wednesday, February, 27th. The company reported $0.00 earnings per share for the quarter. Incannex Healthcare had a negative net margin of 1,129.38% and a negative trailing twelve-month return on equity of 6.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Incannex Healthcare investors own include Tahoe Resources (TAHO), Pharmaxis (PXS), Metalicity (MCT), ECN Capital (ECN), 88 Energy (88E) and Hertz Global (HTZ).

Company Calendar

Last Earnings
2/27/2019
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:IHL
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($1.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$19.98 million
Net Margins
-1,129.38%
Pretax Margin
N/A
Return on Equity
-6.81%
Return on Assets
-17.50%

Debt

Debt-to-Equity Ratio
0.94
Current Ratio
9.02
Quick Ratio
18.80

Sales & Book Value

Annual Sales
A$1.01 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.14
Book Value
A$0.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,590,000,000
Free Float
N/A
Market Cap
A$65.07 million
Optionable
Not Optionable
Beta
2.09
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:IHL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners